Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1234520090040020257
Korean Journal of Urogenital Tract Infection Inflammation
2009 Volume.4 No. 2 p.257 ~ p.263
Yoon Ha-Na

Abstract
Prostatitis and chronic pelvic pain syndrome (CPPS) are diagnosed by symptoms and evidence of inflammation and infection localized to the prostate. Recent improvement in classification and application of modern methods, including molecular biology, should allow proper systematization of treatment.
Acute bacterial prostatitis can be a serious infection. Parenteral administration of high doses of a bactericidal antibiotic is usually required, which may include a broad-spectrum penicillin, a third-generation cephalosporin, or a fluoroquinolone. Treatment is required until there is defeverescence and normalization of infection parameters (IIIB).
In chronic bacterial prostatitis, and if infection is strongly suspected in CPPS, a fluoroquinolone or trimethoprim should be given orally for 2 weeks after the initial diagnosis. Antibiotics only continued if pre-treatment cultures are positive and/or the patient has reported positive effects from the treatment. A total treatment period of 4-6 weeks is recommended (IIIB).
Patients with CPPS are treated empirically with numerous medical and physical modalities. Despite the existence of some scientifically valid studies, no specific recommendations have been made until now.
KEYWORD
Prostatitis, Chronic pelvic pain syndrome, Treatment
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed